Pharma stocks crater as investors brace for billions in heartburn drug litigation charges - CNBC

For many investors and analysts, this ordeal brings back memories of the Bayer Roundup saga.

Shares of GlaxoSmithKline, Sanofi and Haleon all sold off sharply this week, shedding tens of billions in market value, amid investor fear over potential U.S. litigation charges focused on popular he… [+5801 chars]

full article...